For this reason, it is common for RA patients with significant systemic inflammation to develop diabetes mellitus or have insulin or IGF-1 resistance, which in turn can be regulated by inhibiting some proinflammatory cytokines, such as TNF-α [42]. The gene discussed is TNF; the disease is rheumatoid arthritis.